{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:42Z","timestamp":1792153242952,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T00:00:00Z","timestamp":1265155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00415-010-5454-2","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T03:41:05Z","timestamp":1265082065000},"page":"1012-1020","source":"Crossref","is-referenced-by-count":66,"title":["Neurological manifestations of Beh\u00e7et\u2019s disease in Japan: a study of 54 patients"],"prefix":"10.1007","volume":"257","author":[{"given":"Haruko","family":"Ideguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhisa","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,3]]},"reference":[{"key":"5454_CR1","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"issue":"Pt 11","key":"5454_CR2","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behcet\u2019s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122(Pt 11):2171\u20132182","journal-title":"Brain"},{"key":"5454_CR3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP (2009) Neuro-Behcet\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8:192\u2013204","journal-title":"Lancet Neurol"},{"key":"5454_CR4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.74.5.608","volume":"74","author":"A Al-Araji","year":"2003","unstructured":"Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behcet\u2019s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatr 74:608\u2013613","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"5454_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/s10165-006-0541-z","volume":"17","author":"K Aramaki","year":"2007","unstructured":"Aramaki K, Kikuchi H, Hirohata S (2007) HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behcet\u2019s disease. Mod Rheumatol 17:81\u201382","journal-title":"Mod Rheumatol"},{"key":"5454_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-4800(03)80004-7","volume":"74","author":"N Ashjazadeh","year":"2003","unstructured":"Ashjazadeh N, Borhani Haghighi A, Samangooie S, Moosavi H (2003) Neuro-Behcet\u2019s disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet\u2019s disease in 96 Iranian patients. Exp Mol Pathol 74:17\u201322","journal-title":"Exp Mol Pathol"},{"key":"5454_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000247169","volume":"188","author":"G Azizleri","year":"1994","unstructured":"Azizleri G, Aksungur VL, Sarica R, Akyol E, Ovul C (1994) The association of HLA-B5 antigen with specific manifestations of Behcet\u2019s disease. Dermatology 188:293\u2013295","journal-title":"Dermatology"},{"key":"5454_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0039.1992.tb01925.x","volume":"39","author":"A Balboni","year":"1992","unstructured":"Balboni A, Pivetti-Pezzi P, Orlando P, Rubini M, Selvatici R, Accorinti M, Baricordi OR, Gandini E (1992) Serological and molecular HLA typing in Italian Behcet\u2019s patients: significant association to B51-DR5-DQw3 haplotype. Tissue Antigens 39:141\u2013143","journal-title":"Tissue Antigens"},{"key":"5454_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64\u201367","journal-title":"Nature"},{"key":"5454_CR10","first-page":"S21","volume":"22","author":"HK Chang","year":"2004","unstructured":"Chang HK, Lee SS, Bai HJ, Lee YW, Yoon BY, Lee CH, Lee YH, Song GG, Chung WT, Lee SW, Choe JY, Kim CG, Chang DK (2004) Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behcet\u2019s disease: a multi-center study. Clin Exp Rheumatol 22:S21\u2013S26","journal-title":"Clin Exp Rheumatol"},{"key":"5454_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.64.3.382","volume":"64","author":"S Farah","year":"1998","unstructured":"Farah S, Al-Shubaili A, Montaser A, Hussein JM, Malaviya AN, Mukhtar M, Al-Shayeb A, Khuraibet AJ, Khan R, Trontelj JV (1998) Behcet\u2019s syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatr 64:382\u2013384","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"5454_CR12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/40.6.668","volume":"40","author":"A Gul","year":"2001","unstructured":"Gul A, Uyar FA, Inanc M, Ocal L, Tugal-Tutkun I, Aral O, Konice M, Saruhan-Direskeneli G (2001) Lack of association of HLA-B*51 with a severe disease course in Behcet\u2019s disease. Rheumatology (Oxford) 40:668\u2013672","journal-title":"Rheumatology (Oxford)"},{"key":"5454_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","volume":"40","author":"V Hamuryudan","year":"1997","unstructured":"Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, Senocak M, Yazici H (1997) Azathioprine in Behcet\u2019s syndrome: effects on long-term prognosis. Arthritis Rheum 40:769\u2013774","journal-title":"Arthritis Rheum"},{"key":"5454_CR14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kotter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stubiger N, Yurdakul S, Yazici H (2008) EULAR recommendations for the management of Behcet disease. Ann Rheum Dis 67:1656\u20131662","journal-title":"Ann Rheum Dis"},{"key":"5454_CR15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","volume":"68","author":"G Hatemi","year":"2009","unstructured":"Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kotter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stubiger N, Yurdakul S, Yazici H (2009) Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease. Ann Rheum Dis 68:1528\u20131534","journal-title":"Ann Rheum Dis"},{"key":"5454_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","volume":"267","author":"S Hirohata","year":"2008","unstructured":"Hirohata S (2008) Histopathology of central nervous system lesions in Behcet\u2019s disease. J Neurol Sci 267:41\u201347","journal-title":"J Neurol Sci"},{"key":"5454_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata S, Isshi K, Oguchi H, Ohse T, Haraoka H, Takeuchi A, Hashimoto T (1997) Cerebrospinal fluid interleukin-6 in progressive Neuro-Behcet\u2019s syndrome. Clin Immunol Immunopathol 82:12\u201317","journal-title":"Clin Immunol Immunopathol"},{"key":"5454_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/ar757","volume":"5","author":"S Hirohata","year":"2003","unstructured":"Hirohata S, Kikuchi H (2003) Behcet\u2019s disease. Arthritis Res Ther 5:139\u2013146","journal-title":"Arthritis Res Ther"},{"key":"5454_CR19","first-page":"S58","volume":"25","author":"MH Houman","year":"2007","unstructured":"Houman MH, Neffati H, Braham A, Harzallah O, Khanfir M, Miled M, Hamzaoui K (2007) Behcet\u2019s disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 25:S58\u2013S64","journal-title":"Clin Exp Rheumatol"},{"key":"5454_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.47.2.614","volume":"47","author":"K Ikeda","year":"1996","unstructured":"Ikeda K, Abe M, Iwasaki Y, Kinoshita M (1996) Neuro-Behcet\u2019s disease in Japan. Neurology 47:614\u2013615","journal-title":"Neurology"},{"key":"5454_CR21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2006.01613.x","volume":"14","author":"FG Joseph","year":"2007","unstructured":"Joseph FG, Scolding NJ (2007) Neuro-Behcet\u2019s disease in Caucasians: a study of 22 patients. Eur J Neurol 14:174\u2013180","journal-title":"Eur J Neurol"},{"issue":"Pt 11","key":"5454_CR22","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behcet\u2019s syndrome. Brain 122(Pt 11):2183\u20132194","journal-title":"Brain"},{"key":"5454_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Behcet\u2019s syndrome. J Neurol Sci 272:99\u2013105","journal-title":"J Neurol Sci"},{"key":"5454_CR24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjo.81.8.649","volume":"81","author":"DJ Kilmartin","year":"1997","unstructured":"Kilmartin DJ, Finch A, Acheson RW (1997) Primary association of HLA-B51 with Behcet\u2019s disease in Ireland. Br J Ophthalmol 81:649\u2013653","journal-title":"Br J Ophthalmol"},{"key":"5454_CR25","first-page":"1015","volume":"20","author":"N Kocer","year":"1999","unstructured":"Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in neuro-Behcet syndrome: an MR study. AJNR Am J Neuroradiol 20:1015\u20131024","journal-title":"AJNR Am J Neuroradiol"},{"key":"5454_CR26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","volume":"106","author":"S Kotake","year":"1999","unstructured":"Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy. Ophthalmology 106:586\u2013589","journal-title":"Ophthalmology"},{"key":"5454_CR27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60\u201376","journal-title":"Medicine (Baltimore)"},{"key":"5454_CR28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"5454_CR29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0046-8177(85)80250-1","volume":"16","author":"S Lakhanpal","year":"1985","unstructured":"Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T (1985) Pathologic features of Behcet\u2019s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16:790\u2013795","journal-title":"Hum Pathol"},{"key":"5454_CR30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s004150200031","volume":"249","author":"A Lannuzel","year":"2002","unstructured":"Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behcet\u2019s disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410\u2013418","journal-title":"J Neurol"},{"key":"5454_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/crad.2000.0675","volume":"56","author":"SH Lee","year":"2001","unstructured":"Lee SH, Yoon PH, Park SJ, Kim DI (2001) MRI findings in neuro-behcet\u2019s disease. Clin Radiol 56:485\u2013494","journal-title":"Clin Radiol"},{"key":"5454_CR32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-006-0149-9","volume":"26","author":"A Lo Monaco","year":"2006","unstructured":"Lo Monaco A, La Corte R, Caniatti L, Borrelli M, Trotta F (2006) Neurological involvement in North Italian patients with Behcet disease. Rheumatol Int 26:1113\u20131119","journal-title":"Rheumatol Int"},{"key":"5454_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-129-2-199807150-00003","volume":"129","author":"M Margaglione","year":"1998","unstructured":"Margaglione M, Brancaccio V, Giuliani N, D\u2019Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G (1998) Increased risk for venous thrombosis in carriers of the prothrombin G\u2212>\u00a0A20210 gene variant. Ann Intern Med 129:89\u201393","journal-title":"Ann Intern Med"},{"key":"5454_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-0039.1992.tb01953.x","volume":"40","author":"N Mizuki","year":"1992","unstructured":"Mizuki N, Ohno S, Tanaka H, Sugimura K, Seki T, Kera J, Inaba G, Tsuji K, Inoko H (1992) Association of HLA-B51 and lack of association of class II alleles with Behcet\u2019s disease. Tissue Antigens 40:22\u201330","journal-title":"Tissue Antigens"},{"key":"5454_CR35","first-page":"59","volume":"10","author":"Y Mizushima","year":"1988","unstructured":"Mizushima Y (1988) Recent research into Behcet\u2019s disease in Japan. Int J Tissue React 10:59\u201365","journal-title":"Int J Tissue React"},{"key":"5454_CR36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1160\/TH05-10-0659","volume":"95","author":"JM Ricart","year":"2006","unstructured":"Ricart JM, Vaya A, Todoli J, Calvo J, Villa P, Estelles A, Espana F, Santaolaria M, Corella D, Aznar J (2006) Thrombophilic risk factors and homocysteine levels in Behcet\u2019s disease in eastern Spain and their association with thrombotic events. Thromb Haemost 95:618\u2013624","journal-title":"Thromb Haemost"},{"key":"5454_CR37","first-page":"1769","volume":"82","author":"A Ro","year":"1999","unstructured":"Ro A, Hara M, Takada A (1999) The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost 82:1769","journal-title":"Thromb Haemost"},{"key":"5454_CR38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"5454_CR39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/0-306-48382-3_75","volume":"528","author":"A Sbai","year":"2003","unstructured":"Sbai A, Wechsler B, Duhaut P, Du-Boutin LT, Amoura Z, Cacoub P, Godeau P, Piette JC (2003) Neuro-Behcet\u2019s disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up. Adv Exp Med Biol 528:371\u2013376","journal-title":"Adv Exp Med Biol"},{"key":"5454_CR40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","volume":"245","author":"P Serdaroglu","year":"1998","unstructured":"Serdaroglu P (1998) Behcet\u2019s disease and the nervous system. J Neurol 245:197\u2013205","journal-title":"J Neurol"},{"key":"5454_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/art.20237","volume":"51","author":"M Silingardi","year":"2004","unstructured":"Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I (2004) Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet\u2019s disease and deep vein thrombosis. Arthritis Rheum 51:177\u2013183","journal-title":"Arthritis Rheum"},{"key":"5454_CR42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019052-200406000-00017","volume":"17","author":"A Siva","year":"2004","unstructured":"Siva A, Altintas A, Saip S (2004) Behcet\u2019s syndrome and the nervous system. Curr Opin Neurol 17:347\u2013357","journal-title":"Curr Opin Neurol"},{"key":"5454_CR43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behcet\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95\u2013103","journal-title":"J Neurol"},{"key":"5454_CR44","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1755-3768.1992.tb04888.x","volume":"70","author":"M Soylu","year":"1992","unstructured":"Soylu M, Ersoz TR, Erken E (1992) The association between HLA B5 and ocular involvement in Behcet\u2019s disease in southern Turkey. Acta Ophthalmol (Copenh) 70:786\u2013789","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"5454_CR45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","volume":"330","author":"PJ Svensson","year":"1994","unstructured":"Svensson PJ, Dahlback B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517\u2013522","journal-title":"N Engl J Med"},{"key":"5454_CR46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1055\/s-0038-1649866","volume":"74","author":"O Takamiya","year":"1995","unstructured":"Takamiya O, Ishida F, Kodaira H, Kitano K (1995) APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 74:996","journal-title":"Thromb Haemost"},{"key":"5454_CR47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-4362.2003.01741.x","volume":"42","author":"U Tursen","year":"2003","unstructured":"Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet\u2019s disease. Int J Dermatol 42:346\u2013351","journal-title":"Int J Dermatol"},{"key":"5454_CR48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yazici","year":"2007","unstructured":"Yazici H, Fresko I, Yurdakul S (2007) Behcet\u2019s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148\u2013155","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5454-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5454-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:12:56Z","timestamp":1559056376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5454-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,3]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["5454"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5454-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,3]]}}}